Insights

Innovative R&D Focus General Probiotics is leveraging AI-enabled research grants from the US National Science Foundation and USDA, showcasing their cutting-edge approach to antimicrobial medicine development. This focus on innovation suggests opportunities to collaborate or integrate with organizations seeking advanced biotech solutions.

Niche Market Position With a specialized product line of advanced probiotics targeting pathogens, GP operates within a growing segment of antimicrobial and microbiome-based therapies. This niche positioning creates potential for partnerships with healthcare providers and biotech distributors interested in novel infectious disease treatments.

Emerging Market Potential Given their early-stage revenue of under one million dollars and small team size, General Probiotics is in a growth phase with significant expansion potential. Engaging with the company early could offer a strategic advantage in establishing product or technology partnerships as they scale.

Funding and Grants Advantage The company's receipt of government grants indicates strong research backing and a focus on innovation, making them a promising candidate for future funding collaborations or joint ventures with organizations interested in biotech advancements or research commercialization.

Technology Integration Opportunities Utilizing a modern tech stack including MySQL, Nginx, and APIs, GP is positioned to adopt or integrate advanced software solutions. This provides opportunities to offer complementary tech services or tools that support their R&D activities or improve operational efficiencies.

General Probiotics, Inc. Tech Stack

General Probiotics, Inc. uses 8 technology products and services including MySQL, oEmbed, Google Fonts API, and more. Explore General Probiotics, Inc.'s tech stack below.

  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Priority Hints
    Performance
  • Nginx
    Web Servers
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Media & News

General Probiotics, Inc.'s Email Address Formats

General Probiotics, Inc. uses at least 1 format(s):
General Probiotics, Inc. Email FormatsExamplePercentage
First@gprobiotics.comJohn@gprobiotics.com
100%

Frequently Asked Questions

Where is General Probiotics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
General Probiotics, Inc.'s main headquarters is located at 1000 Westgate Drive St. Paul, Minnesota 55114 United States. The company has employees across 1 continents, including North America.

What is General Probiotics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
General Probiotics, Inc.'s official website is gprobiotics.com and has social profiles on LinkedInCrunchbase.

What is General Probiotics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
General Probiotics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does General Probiotics, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, General Probiotics, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Cfo: M. W.Founder And Ceo: Y. K.Senior Engineer: K. G.. Explore General Probiotics, Inc.'s employee directory with LeadIQ.

What industry does General Probiotics, Inc. belong to?

Minus sign iconPlus sign icon
General Probiotics, Inc. operates in the Biotechnology Research industry.

What technology does General Probiotics, Inc. use?

Minus sign iconPlus sign icon
General Probiotics, Inc.'s tech stack includes MySQLoEmbedGoogle Fonts APIjQuery MigratePriority HintsNginxApache HTTP ServerApache.

What is General Probiotics, Inc.'s email format?

Minus sign iconPlus sign icon
General Probiotics, Inc.'s email format typically follows the pattern of First@gprobiotics.com. Find more General Probiotics, Inc. email formats with LeadIQ.

How much funding has General Probiotics, Inc. raised to date?

Minus sign iconPlus sign icon
As of April 2026, General Probiotics, Inc. has raised $256K in funding. The last funding round occurred on Sep 02, 2020 for $256K.

When was General Probiotics, Inc. founded?

Minus sign iconPlus sign icon
General Probiotics, Inc. was founded in 2014.

General Probiotics, Inc.

Biotechnology ResearchMinnesota, United States2-10 Employees

General Probiotics (GP) is a biotechnology company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases.

GP engineers are world leaders in advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably.

GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the US Department of Agriculture to pursue an unparalleled, AI-enabled R&D program.

Section iconCompany Overview

Headquarters
1000 Westgate Drive St. Paul, Minnesota 55114 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $256K

    General Probiotics, Inc. has raised a total of $256K of funding over 3 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $256K.

  • $1M

    General Probiotics, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $256K

    General Probiotics, Inc. has raised a total of $256K of funding over 3 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $256K.

  • $1M

    General Probiotics, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.